Page last updated: 2024-08-23

alovudine and Head and Neck Neoplasms

alovudine has been researched along with Head and Neck Neoplasms in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (20.83)29.6817
2010's18 (75.00)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Bak, B; Cegła, P; Cholewinski, W; Kazmierska, J; Malicki, J; Piotrowski, T; Sowinska, A1
Cegla, P; Joanna, K; Julian, M; Michal, S; Sebastian, G; Witold, C1
Fatema, CN; Kitagawa, Y; Kuge, Y; Murakami, M; Nishijima, K; Tamaki, N; Yu, W; Zhao, S; Zhao, Y1
Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y1
Buatti, JM; Menda, Y1
Arens, AI; Bussink, J; Grégoire, V; Grootjans, W; Hatt, M; Hoeben, BA; Kaanders, JH; Lee, JA; Oyen, WJ; Troost, EG; Visser, EP; Visvikis, D1
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Troost, EG; van Herpen, CM1
Chalkidou, A; Fenwick, JD; Landau, DB; Liu, D; Marsden, PK1
Bai, GH; Cabrera, AR; Lee, J; Li, YH; Liu, J; Sun, XD; Yang, J; Yu, JM; Yue, JB1
Fukumura, T; Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Samukawa, Y; Yamamoto, Y2
Boellaard, R; de Bree, R; de Langen, AJ; Hoekstra, OS; Klabbers, B; Lammertsma, AA; Lubberink, M; Slotman, BJ; Smit, EF; Spreeuwenberg, MD1
Boles Ponto, LL; Buatti, JM; Dornfeld, KJ; Graham, MM; Menda, Y; Schultz, MK; Sunderland, JJ; Tewson, TJ; Watkins, GL1
Buck, AK; Fayad, L; Graham, MM; Herrmann, K; Juweid, ME; Menda, Y; Tewson, T; Thomas, D1
Anderson, C; Buatti, JM; Dornfeld, KJ; Graham, MM; Gupta, AK; McGuire, S; Menda, Y; Ponto, LL; Schultz, MK; Sunderland, JJ; Tewson, TJ; Watkins, GL1
Boles Ponto, LL; Buatti, J; Dornfeld, K; Graham, MM; Menda, Y; Sunderland, J; Tewson, TJ; Watkins, GL1
Bayouth, JE; Boles Ponto, LL; Buatti, J; Gross, B; McGuire, SM; Menda, Y1
Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y1
Fukumura, T; Hasegawa, A; Inubushi, M; Kamada, T; Koizumi, M; Koto, M; Morikawa, T; Saga, T; Takagi, R; Tanimoto, K; Wakatuki, M; Yamada, S; Yoshikawa, K1
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Span, PN; Troost, EG; van Herpen, CM1
Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y1
Bussink, J; Kaanders, JH; Marres, HA; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ; Vogel, WV1
Atkinson, DM; Carlson, BL; Clarke, MJ; Jacobson, MS; Kemp, BJ; Lowe, VJ; Mladek, AC; Sarkaria, JN; Trump, DP1
Angelberger, P; Becherer, A; Dudczak, R; Ewers, R; Kermer, C; Kletter, K; Linecker, A; Sulzbacher, I1

Trials

7 trial(s) available for alovudine and Head and Neck Neoplasms

ArticleYear
Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:7

    Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Computer Simulation; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant

2009
Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:4

    Topics: Bone Marrow; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors

2010
Stability of 3'-deoxy-3'-[18F]fluorothymidine standardized uptake values in head and neck cancer over time.
    Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:3

    Topics: Aged; Carboplatin; Cisplatin; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors

2010
Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Annals of nuclear medicine, 2013, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Heavy Ion Radiotherapy; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome

2013
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Biological Transport; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Treatment Outcome

2013
Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
    Annals of nuclear medicine, 2013, Volume: 27, Issue:4

    Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2013
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Pseudolymphoma; Radiopharmaceuticals; Treatment Outcome

2007

Other Studies

17 other study(ies) available for alovudine and Head and Neck Neoplasms

ArticleYear
Assessment of tumour hypoxia, proliferation and glucose metabolism in head and neck cancer before and during treatment.
    The British journal of radiology, 2020, Feb-01, Volume: 93, Issue:1106

    Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Chemoradiotherapy; Cisplatin; Dideoxynucleosides; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation-Sensitizing Agents; Treatment Outcome; Tumor Hypoxia

2020
Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer.
    Nuclear medicine communications, 2019, Volume: 40, Issue:7

    Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Misonidazole; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radioactive Tracers

2019
Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67.
    Annals of nuclear medicine, 2013, Volume: 27, Issue:4

    Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2013
The value of 18F-FLT PET for detecting second primary cancers and distant metastases in head and neck cancer patients.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity

2013
PET imaging during radiotherapy of head and neck cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:4

    Topics: Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Positron-Emission Tomography

2013
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:5

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden

2014
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
    Nuklearmedizin. Nuclear medicine, 2014, Volume: 53, Issue:2

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2014
18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.
    Medical physics, 2014, Volume: 41, Issue:4

    Topics: Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Kinetics; Models, Biological; Positron-Emission Tomography

2014
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 111, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Dideoxynucleosides; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2014
Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:10

    Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden

2014
Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden

2015
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3

    Topics: Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results

2009
PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5

    Topics: Dideoxynucleosides; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Lymphoma; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed

2010
3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.
    International journal of radiation oncology, biology, physics, 2011, Nov-01, Volume: 81, Issue:3

    Topics: Bone Marrow; Bone Marrow Cells; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed

2011
Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome

2012
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
    Head & neck, 2008, Volume: 30, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Dideoxynucleosides; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines

2008
Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival.
    Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radioisotopes; Survival Analysis

2008